Etomidate

CHEMBL681 Phase 4 승인됨 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
244.3 g/mol
LogP
3.0
Phase
4

This fast-acting intravenous medication is used to induce general anesthesia before surgical procedures. It works by enhancing GABA activity to cause rapid loss of consciousness with minimal effects on heart function.

분자량

244.2900 g/mol

LogP

3.00

TPSA

44.10 Ų

리핀스키 5의 법칙

통과

치료 영역

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCOC(=O)c1cncn1[C@H](C)c1ccccc1

InChI

InChI=1S/C14H16N2O2/c1-3-18-14(17)13-9-15-10-16(13)11(2)12-7-5-4-6-8-12/h4-11H,3H2,1-2H3/t11-/m1/s1

Molecular Formula

C14H16N2O2

HBD / HBA

- / 3

회전 가능 결합

5

무거운 원자

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

This fast-acting intravenous medication is used to induce general anesthesia before surgical procedures. It works by enhancing GABA activity to cause rapid loss of consciousness with minimal effects on heart function.

Yes, Etomidate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL681. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 667484. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.